Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fatty Liver Disease”

2,086 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,086 results

Not applicableUnknownNCT02493153
What this trial is testing

Hepatic Steatosis After Cholecystectomy

Who this might be right for
Hepatic Steatosis
Sangchul Yun 82
Testing effectiveness (Phase 2)Study completedNCT03976401
What this trial is testing

Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 110
Large-scale testing (Phase 3)Not Yet RecruitingNCT06691412
What this trial is testing

Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes

Who this might be right for
Hepatitis B VirusSteatosis
Assiut University 100
Not applicableWithdrawnNCT03302481
What this trial is testing

Mitochondrial Metabolism and Hepatic Complications of Obesity

Who this might be right for
Obesity
Nantes University Hospital
Large-scale testing (Phase 3)Study completedNCT02535195
What this trial is testing

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

Who this might be right for
Non-alcoholic Fatty Liver Disease
Dr Azita Hekmatdoost 60
Not applicableStudy completedNCT03942822
What this trial is testing

Chia Supplementation and Non Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDietary Modification
Instituto Nacional de Cardiologia Ignacio Chavez 40
Not applicableUnknownNCT01927133
What this trial is testing

LIVER FIBROSIS PREVALENCE IN FRANCE

Who this might be right for
Liver Fibrosis Progression in Chronic Liver Disease
Assistance Publique - Hôpitaux de Paris 10,000
Not applicableUnknownNCT05422092
What this trial is testing

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03867487
What this trial is testing

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD
Justin Ryder 40
Not applicableStudy completedNCT02390232
What this trial is testing

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
University Hospital, Toulouse 176
Testing effectiveness (Phase 2)Study completedNCT01094158
What this trial is testing

Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisMetabolic Syndrome
Galmed Medical Reserch 60
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Not applicableLooking for participantsNCT05720663
What this trial is testing

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Virginia Commonwealth University 240
Not applicableStudy completedNCT04668664
What this trial is testing

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

Who this might be right for
Liver CirrhosisLiver DiseasesHypertension, Portal
Cook Research Incorporated 70
Not applicableStudy completedNCT04800094
What this trial is testing

Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Steatohepatitis
Philips Clinical & Medical Affairs Global 30
Early research (Phase 1)Study completedNCT03610945
What this trial is testing

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 48
Early research (Phase 1)Study completedNCT00816465
What this trial is testing

Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hadassah Medical Organization 20
Not applicableUnknownNCT03844165
What this trial is testing

Fighting Fatty Liver in India

Who this might be right for
NAFLD
University of Nottingham 84
Testing effectiveness (Phase 2)Study completedNCT01205087
What this trial is testing

Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

Who this might be right for
Nonalcoholic Steatohepatitis
Hadassah Medical Organization 36
Load More Results